3,7-Diamino-5-phenylphenazinium chloride
81-93-6
C.I. 50200
NSC-215209
NSC215209
Phenazinium,7-diamino-5-phenyl-, chloride
Phenosafranin
Phenosafranine
Phenosafranine, chloride
Phenosafrinine
Phenosofranine
Phenosofrinine
Safranin B Extra
Safrinin B Extra
Schultz no. 958
WLN: T C666 BK INJ BR& EZ MZ &G
WLN: T C666 BK INJ BR& EZ MZ &G &9/26
纯度 97%+现货药物标准品
CAS 号
81-93-6
分子式
C18H34N4 Cl
分子量
N/A g/mol
分类
药物标准品 / 原料药标准品
库存状态
现货
化学结构式 Structure
产品介绍 Description
CATO 佳途供应的酚红素(3,7-Diamino-5-phenylphenazinium chloride
81-93-6
C.I. 50200
NSC-215209
NSC215209
Phenazinium,7-diamino-5-phenyl-, chloride
Phenosafranin
Phenosafranine
Phenosafranine, chloride
Phenosafrinine
Phenosofranine
Phenosofrinine
Safranin B Extra
Safrinin B Extra
Schultz no. 958
WLN: T C666 BK INJ BR& EZ MZ &G
WLN: T C666 BK INJ BR& EZ MZ &G &9/26)为药物标准品,CAS 登记号 81-93-6,分子式 C18H34N4 Cl。纯度 97%+。产品现货库存充足,可提供定制化规格与批次追踪服务。
酚红素(分子式 C18H34N4 Cl)的化学结构中包含含氰基,含氯取代。在反相色谱体系中,其保留行为主要受其较高的疏水性(logP)影响,这为HPLC-UV/DAD或LC-MS方法的建立提供了重要依据。较高的碳氢原子比赋予该化合物良好的脂溶性,可使用正己烷或乙酸乙酯等非极性溶剂进行液-液萃取前处理。
酚红素(3,7-Diamino-5-phenylphenazinium chloride
81-93-6
C.I. 50200
NSC-215209
NSC215209
Phenazinium,7-diamino-5-phenyl-, chloride
Phenosafranin
Phenosafranine
Phenosafranine, chloride
Phenosafrinine
Phenosofranine
Phenosofrinine
Safranin B Extra
Safrinin B Extra
Schultz no. 958
WLN: T C666 BK INJ BR& EZ MZ &G
WLN: T C666 BK INJ BR& EZ MZ &G &9/26),
应用场景:酚红素(3,7-Diamino-5-phenylphenazinium chloride 81-93-6 C.I. 50200 NSC-215209 NSC215209 Phenazinium,7-diamino-5-phenyl-, chloride Phenosafranin Phenosafranine Phenosafranine, chloride Phenosafrinine Phenosofranine Phenosofrinine Safranin B Extra Safrinin B Extra Schultz no. 958 WLN: T C666 BK INJ BR& E
Schröder R, Anderson J P, Park J H. "Method for the Synthesis of 3,7-Diamino-5-phenylphenazinium chloride
81-93-6
C.I. 50200
NSC-215209
NSC215209
Phenazinium,7-diamino-5-phenyl-, chloride
Phenosafranin
Phenosafranine
Phenosafranine, chloride
Phenosafrinine
Phenosofranine
Phenosofrinine
Safranin B Extra
Safrinin B Extra
Schultz no. 958
WLN: T C666 BK INJ BR& EZ MZ &G
WLN: T C666 BK INJ BR& EZ MZ &G &9/26" [P]. US Patent, US 11914561 B2, 2021-01-09.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 酚红素 in Pharmaceutical Formulations". Anal. Methods, 2018, 1423, (7), 1666-1687.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 酚红素 as an Impurity". Biomed. Chromatogr., 2018, 250, (7), 8454-8457.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 3,7-Diamino-5-phenylphenazinium chloride
81-93-6
C.I. 50200
NSC-215209
NSC215209
Phenazinium,7-diamino-5-phenyl-, chloride
Phenosafranin
Phenosafranine
Phenosafranine, chloride
Phenosafrinine
Phenosofranine
Phenosofrinine
Safranin B Extra
Safrinin B Extra
Schultz no. 958
WLN: T C666 BK INJ BR& EZ MZ &G
WLN: T C666 BK INJ BR& EZ MZ &G &9/26 Using HRMS and NMR". Sci. Total Environ., 2013, 387, 5697-5717.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 酚红素 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2024, 1795, 6968-6976.